Effect of a 0.5% dilution of propofol on pain on injection during induction of anesthesia in children. 2007

Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
Department of Anesthesia and Intensive Care Medicine, Hospital Leverkusen, and University of Rostock, Rostock, Germany. soltesz@klinikum-lev.de

BACKGROUND Pain on injection of propofol in children has been reported to be as high as 30-80%. The reason for the pain is assumed to be the aqueous phase of the propofol emulsion. Therefore, for the first time, this study tested the hypothesis that dilution of propofol to a 0.5% emulsion might reduce the incidence of pain during propofol injection. METHODS The study design was prospective, monocenter, double-blind, and randomized. Sixty-four children aged 2-6 yr were scheduled to receive 0.5% or 1.0% propofol in a medium-chain-triglyceride/long-chain-triglyceride emulsion. Incidence and intensity of pain were assessed by spontaneous expressions of pain and withdrawal of the arm. In a subgroup of 21 children, serum triglyceride levels were measured before and 3 and 20 min after induction. Adverse events were recorded. RESULTS Amounts of propofol required until loss of eyelash reflex were 4.40+/-1.01 mg/kg for 0.5% propofol and 4.31+/-0.86 mg/kg for 1.0% propofol. Percentages of children who showed at least one pain reaction were 23.3% in the 0.5% propofol group and 70.0% in the 1.0% propofol group (P<0.001). Serum triglycerides were higher in the 0.5% propofol group 3 and 20 min after injection (251.7 vs. 148.8 mg/dl; P=0.001 and 135.5 vs. 75.5 mg/dl; P=0.03). Adverse events or complications did not occur. CONCLUSIONS Dilution of propofol to a 0.5% medium-chain-triglyceride/long-chain-triglyceride emulsion reduced pain effectively during injection in children aged 2-6 yr. Cumulative doses until 4-5 mg/kg propofol led to moderate increases of triglyceride levels and did not result in significant adverse events.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008297 Male Males
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
March 2012, European journal of anaesthesiology,
Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
January 1991, Cahiers d'anesthesiologie,
Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
April 2020, Anesthesia and pain medicine,
Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
April 2022, Anesthesia and pain medicine,
Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
December 2004, Anaesthesia and intensive care,
Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
July 2009, Masui. The Japanese journal of anesthesiology,
Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
February 1989, Acta anaesthesiologica Scandinavica,
Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
August 2020, European journal of clinical pharmacology,
Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
July 2011, Saudi journal of anaesthesia,
Stefan Soltész, and Malte Silomon, and Gerhard Gräf, and Thomas Mencke, and Sabiha Boulaadass, and Gerd P Molter
February 1995, Anaesthesia,
Copied contents to your clipboard!